SNAPSHOT ACS Cohort Follow-Up – What Happens to Australian Patients in the 3 Years after Hospital Discharge: A National Data Linkage Study

SNAPSHOT ACS Investigators

doi:https://doi.org/10.1016/j.hlc.2019.06.558

Abstract

Aim: High quality person-centred data linkage in all-comers admitted for suspected acute coronary syndrome (ACS) provides robust population estimates of mortality and morbidity. This study aimed to determine the proportion of patients hospitalised, deaths and medication dispensed at 6, 12, 24 and 36 months post ACS.

Methods: The original Australian SNAPSHOT ACS cohort included 3381patients admitted to 252 hospitals from 14–27 May 2012. For the present study, the 1773 Australian patients who were discharged alive with a primary diagnosis of ACS were followed-up via data linkage of cross-jurisdictional morbidity, National Death Index and Pharmaceutical Benefit Schedule at time points from the date of hospital separation.

Results: All ACS patients who were discharged alive with data successfully linked (n = 1663) had a mean age of 68 ± 13 years, 1088 (65%) were male. In total, during the 36 months after discharge 302 (18%) patients died and 536 (39%) had at least one hospitalisation for cardiovascular disease (CVD) as detailed in Table 1. Among survivors at 36 months, medications dispensed included antiplatelets 75%, statins 85%, beta-blockers 60%, ACEI/ARBs 64%. In total, ≥3 evidenced-based medications were dispensed for 70% of patients.

Original language	English
Article number	S373
Number of pages	1
Journal	Heart, Lung and Circulation
Volume	28
Issue number	Supp 4
DOIs	https://doi.org/10.1016/j.hlc.2019.06.558
Publication status	Published - 24 Jun 2019

Keywords

Hospital Discharge
Australian Patients

Access to Document

https://doi.org/10.1016/j.hlc.2019.06.558Licence: In Copyright

Fingerprint Dive into the research topics of 'SNAPSHOT ACS Cohort Follow-Up – What Happens to Australian Patients in the 3 Years after Hospital Discharge: A National Data Linkage Study'. Together they form a unique fingerprint.

Cite this

@article{f21204849ba747b081c76c14c9af4be1,

title = "SNAPSHOT ACS Cohort Follow-Up – What Happens to Australian Patients in the 3 Years after Hospital Discharge: A National Data Linkage Study",

abstract = "Aim: High quality person-centred data linkage in all-comers admitted for suspected acute coronary syndrome (ACS) provides robust population estimates of mortality and morbidity. This study aimed to determine the proportion of patients hospitalised, deaths and medication dispensed at 6, 12, 24 and 36 months post ACS.Methods: The original Australian SNAPSHOT ACS cohort included 3381patients admitted to 252 hospitals from 14–27 May 2012. For the present study, the 1773 Australian patients who were discharged alive with a primary diagnosis of ACS were followed-up via data linkage of cross-jurisdictional morbidity, National Death Index and Pharmaceutical Benefit Schedule at time points from the date of hospital separation.Results: All ACS patients who were discharged alive with data successfully linked (n = 1663) had a mean age of 68 ± 13 years, 1088 (65%) were male. In total, during the 36 months after discharge 302 (18%) patients died and 536 (39%) had at least one hospitalisation for cardiovascular disease (CVD) as detailed in Table 1. Among survivors at 36 months, medications dispensed included antiplatelets 75%, statins 85%, beta-blockers 60%, ACEI/ARBs 64%. In total, ≥3 evidenced-based medications were dispensed for 70% of patients.",

keywords = "Hospital Discharge, Australian Patients",

author = "J Redfern and K Hyun and D Brieger and D Chew and J French and C Hammett and C Ellis and C Astley and B Carr and J Lefkovits and K Nalliaih and K Lintern and T Briffa and {SNAPSHOT ACS Investigators}",

year = "2019",

month = jun,

day = "24",

doi = "https://doi.org/10.1016/j.hlc.2019.06.558",

language = "English",

volume = "28",

journal = "Heart, Lung and Circulation",

issn = "1443-9506",

publisher = "Science Direct",

number = "Supp 4",

}

TY - JOUR

T1 - SNAPSHOT ACS Cohort Follow-Up – What Happens to Australian Patients in the 3 Years after Hospital Discharge

T2 - A National Data Linkage Study

AU - Redfern, J

AU - Hyun, K

AU - Brieger, D

AU - Chew, D

AU - French, J

AU - Hammett, C

AU - Ellis, C

AU - Astley, C

AU - Carr, B

AU - Lefkovits, J

AU - Nalliaih, K

AU - Lintern, K

AU - Briffa, T

AU - SNAPSHOT ACS Investigators

PY - 2019/6/24

Y1 - 2019/6/24

N2 - Aim: High quality person-centred data linkage in all-comers admitted for suspected acute coronary syndrome (ACS) provides robust population estimates of mortality and morbidity. This study aimed to determine the proportion of patients hospitalised, deaths and medication dispensed at 6, 12, 24 and 36 months post ACS.Methods: The original Australian SNAPSHOT ACS cohort included 3381patients admitted to 252 hospitals from 14–27 May 2012. For the present study, the 1773 Australian patients who were discharged alive with a primary diagnosis of ACS were followed-up via data linkage of cross-jurisdictional morbidity, National Death Index and Pharmaceutical Benefit Schedule at time points from the date of hospital separation.Results: All ACS patients who were discharged alive with data successfully linked (n = 1663) had a mean age of 68 ± 13 years, 1088 (65%) were male. In total, during the 36 months after discharge 302 (18%) patients died and 536 (39%) had at least one hospitalisation for cardiovascular disease (CVD) as detailed in Table 1. Among survivors at 36 months, medications dispensed included antiplatelets 75%, statins 85%, beta-blockers 60%, ACEI/ARBs 64%. In total, ≥3 evidenced-based medications were dispensed for 70% of patients.

AB - Aim: High quality person-centred data linkage in all-comers admitted for suspected acute coronary syndrome (ACS) provides robust population estimates of mortality and morbidity. This study aimed to determine the proportion of patients hospitalised, deaths and medication dispensed at 6, 12, 24 and 36 months post ACS.Methods: The original Australian SNAPSHOT ACS cohort included 3381patients admitted to 252 hospitals from 14–27 May 2012. For the present study, the 1773 Australian patients who were discharged alive with a primary diagnosis of ACS were followed-up via data linkage of cross-jurisdictional morbidity, National Death Index and Pharmaceutical Benefit Schedule at time points from the date of hospital separation.Results: All ACS patients who were discharged alive with data successfully linked (n = 1663) had a mean age of 68 ± 13 years, 1088 (65%) were male. In total, during the 36 months after discharge 302 (18%) patients died and 536 (39%) had at least one hospitalisation for cardiovascular disease (CVD) as detailed in Table 1. Among survivors at 36 months, medications dispensed included antiplatelets 75%, statins 85%, beta-blockers 60%, ACEI/ARBs 64%. In total, ≥3 evidenced-based medications were dispensed for 70% of patients.

KW - Hospital Discharge

KW - Australian Patients

U2 - https://doi.org/10.1016/j.hlc.2019.06.558

DO - https://doi.org/10.1016/j.hlc.2019.06.558

M3 - Meeting Abstract

VL - 28

JO - Heart, Lung and Circulation

JF - Heart, Lung and Circulation

SN - 1443-9506

IS - Supp 4

M1 - S373

ER -